372 related articles for article (PubMed ID: 36187294)
21. A Pair of "ACEs".
Hersh EV; Wolff M; Moore PA; Theken KN; Daniell H
J Dent Res; 2022 Jan; 101(1):5-10. PubMed ID: 34689655
[TBL] [Abstract][Full Text] [Related]
22. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
23. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
24. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis.
Moreira FRC; de Oliveira TA; Ramos NE; Abreu MAD; Simões E Silva AC
Mol Biol Rep; 2021 Sep; 48(9):6619-6629. PubMed ID: 34417705
[TBL] [Abstract][Full Text] [Related]
25. Impacts of SARS-CoV-2 on brain renin angiotensin system related signaling and its subsequent complications on brain: A theoretical perspective.
Etebar N; Naderpour S; Akbari S; Zali A; Akhlaghdoust M; Daghighi SM; Baghani M; Sefat F; Hamidi SH; Rahimzadegan M
J Chem Neuroanat; 2024 Jul; 138():102423. PubMed ID: 38705215
[TBL] [Abstract][Full Text] [Related]
26. Many Faces of Renin-angiotensin System - Focus on Eye.
Holappa M; Vapaatalo H; Vaajanen A
Open Ophthalmol J; 2017; 11():122-142. PubMed ID: 28761566
[TBL] [Abstract][Full Text] [Related]
27. The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.
Meng Y; Li T; Zhou GS; Chen Y; Yu CH; Pang MX; Li W; Li Y; Zhang WY; Li X
Antioxid Redox Signal; 2015 Jan; 22(3):241-58. PubMed ID: 25089563
[TBL] [Abstract][Full Text] [Related]
28. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
Steckelings UM; Sumners C
Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
[TBL] [Abstract][Full Text] [Related]
29. ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke.
Jiang T; Gao L; Lu J; Zhang YD
Curr Neuropharmacol; 2013 Mar; 11(2):209-17. PubMed ID: 23997755
[TBL] [Abstract][Full Text] [Related]
30. Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment.
Chappell MC
Circ Res; 2023 May; 132(10):1320-1337. PubMed ID: 37167353
[TBL] [Abstract][Full Text] [Related]
31. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
32. The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.
Lumbers ER; Head R; Smith GR; Delforce SJ; Jarrott B; H Martin J; Pringle KG
Pharmacol Res Perspect; 2022 Feb; 10(1):e00917. PubMed ID: 35106954
[TBL] [Abstract][Full Text] [Related]
33. COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review.
Salgo MP
Infect Dis Ther; 2021 Sep; 10(3):1215-1225. PubMed ID: 34251655
[TBL] [Abstract][Full Text] [Related]
34. Renin-angiotensin system and inflammation update.
Cantero-Navarro E; Fernández-Fernández B; Ramos AM; Rayego-Mateos S; Rodrigues-Diez RR; Sánchez-Niño MD; Sanz AB; Ruiz-Ortega M; Ortiz A
Mol Cell Endocrinol; 2021 Jun; 529():111254. PubMed ID: 33798633
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
37. The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations.
Maranduca MA; Vamesu CG; Tanase DM; Clim A; Drochioi IC; Pinzariu AC; Filip N; Dima N; Tudorancea I; Serban DN; Serban IL
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556919
[TBL] [Abstract][Full Text] [Related]
38. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
39. ACE2, the Counter-Regulatory Renin-Angiotensin System Axis and COVID-19 Severity.
Triposkiadis F; Xanthopoulos A; Giamouzis G; Boudoulas KD; Starling RC; Skoularigis J; Boudoulas H; Iliodromitis E
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501332
[TBL] [Abstract][Full Text] [Related]
40. The fight against COVID-19: Striking a balance in the renin-angiotensin system.
Dean AQ; Bozza WP; Twomey JD; Luo S; Nalli A; Zhang B
Drug Discov Today; 2021 Oct; 26(10):2214-2220. PubMed ID: 33865979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
